In 2008, it is estimated that 148,810 new cases of colorectal cancer (CRC) will be diagnosed
in the United States and that 49,960 people will die from the disease (1); lung cancer is the …

When used appropriately, screening for colorectal cancer (CRC) can reduce disease-related
morbidity and mortality. Current methods include fecal occult blood testing (FOBT), flexible …

Worldwide, colorectal cancer (CRC) is the third most common cancer among men and
second most common cancer among women (1). Screening can reduce CRC incidence and …

Colorectal cancer (CRC) accounts for up to 9% of new malignancies worldwide, and affects
more than one million people annually. 1 Screening for CRC not makes the early detection …

Colorectal cancer (CRC) remains a leading cause of cancer incidence and mortality in the
United States. 1 CRC takes a particularly high toll on African Americans, who suffer a …

Objective We conducted this systematic review to support the US Preventive Services Task
Force in updating its recommendation on screening for colorectal cancer (CRC). Our review …

Several strategies for colorectal cancer screening in persons at average risk are
recommended by the Agency for Health Care Policy and Research, the American College of …

Importance Colorectal cancer is the second leading cause of cancer death in the United
States. In 2016, an estimated 134 000 persons will be diagnosed with the disease, and …

Context Screening for colorectal cancer clearly reduces colorectal cancer mortality, yet many
eligible adults remain unscreened. Several screening tests are available, and various …

Importance Colorectal cancer (CRC) remains a significant cause of morbidity and mortality
in the US. Objective To systematically review the effectiveness, test accuracy, and harms of …